Pricing Log in Create free account

Genenta Science S.p.A. Unsponsored ADR (GNTA) vs Metagenomi Therapeutics, Inc. (MGX)

Genenta Science S.p.A. Unsponsored ADR and Metagenomi Therapeutics, Inc. are both Biotechnology companies. Genenta Science S.p.A. Unsponsored ADR and Metagenomi Therapeutics, Inc. are of similar size ($32.3M and $31.9M). Across the 8 metrics below, Genenta Science S.p.A. Unsponsored ADR leads on 6 and Metagenomi Therapeutics, Inc. on 2.

Valuation

Metric GNTA MGX Biotechnology median
P/E — n/m 8.50
P/S n/m 2.17 9.71
P/B n/m 0.26 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.63 0.64
EV/Sales n/m (4.50) 9.21
Earnings yield — (319.23%) (33.15%)
Free cash flow yield 0.00% (292.09%) (25.50%)

Profitability

Metric GNTA MGX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin — (741.58%) 0.00%
Net margin — (689.20%) 0.00%
Free cash flow margin 0.00% (632.67%) 0.00%
Return on equity 0.00% (60.61%) (56.36%)
Return on assets 0.00% (41.91%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNTA MGX Biotechnology median
Revenue growth (TTM) — (59.84%) 6.02%
EPS growth (last fiscal year) 30.19% 0.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GNTA MGX Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 14.16 4.50 4.72
Net debt to EBITDA 3.12 1.71 0.96

Dividend

Metric GNTA MGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNTA MGX Biotechnology median
Market cap 32.28m 31.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack